911±¬ÁÏÍø

XClose

LMCB - Laboratory for Molecular Cell Biology

Home
Menu

Publication in Cardiology Research for Kriston-Vizi and Ketteler

A new study by Kalkhoran et al, , showsÌýhydralazine, a drugÌýused to treat patients with hypertension and chronic heart failure, can reduceÌýheart attack size and heart muscle cell deathÌýby inhibiting mitochondrial fission.Ìý

Figure caption: Segmented mitochondria fragments after processing of a 63x fluorescence image, acquired with Opera high-content screening system.